BioWorld® - Medical Device Daily

BioWorld Industrial Biotechnology StatReport: Immediate and Comprehensive Industry Information
Gentris Corp. Gentris can create, use
and sale of diagnostic
products and services
which include testing for
the CYP2D6*4
polymorphism in the
U.S.
non-exclusive
licensing agreement
RESEARCH & DEVELOPMENT: Bioanalytical and genetic diagnostics and detection methodologies
DNA analytical technologies
Reference standards
PRODUCTS ON MARKET: Analytical services/consultancy
Paternity testing
Forensics
Livestock genotyping
GMOs
DNA databasing/analysis
BSE testing
Reference standards
LifeCell Corp.
One Millennium Way
Branchburg NJ 08876-3876, US
Phone: (908) 947-1100; Fax: (908) 947-1089
Toll-free phone: (800) 367-5737
Web: www.lifecell.com
E-mail: corporatecommunications@lifecell.com
KEY PERSONNEL: Paul G. Thomas; Chairman, President and CEO
Steven T. Sobieski; VP, Finance and Administration and CFO
Lisa N. Colleran; Sr. VP, Commercial Operations
Dr. Bruce Lamb; Sr. VP, Development, Regulatory Affairs and Quality
Young C. McGuinn; VP, Manufacturing Operations
EMPLOYEES: 269 employees
HISTORY: Formed in 1986 by a technology transfer from the University of Texas Health
Science Center in Houston to commercialize patented biopreservation
technology
Member--Biotechnology Industry Organization
FACILITIES: 90,000 sq. ft. of leased office, laboratory, production and warehouse space
STOCK-FINANCIAL HISTORY: NASDAQ--LIFC
IPO--800K units, each unit consisting of one share of common stock and
one warrant to purchase 1/2 share of common stock, at $7.75/unit (2/92)
Public offering--4M shares at $4.50/share, $18M (11/97)
Revenue $94.398M (YE 05) compared to $61.127M (YE 04)
Net income $12.044M (YE 05) compared to $7.184M (YE 04)
Earnings per share $0.39/share (YE 05) compared to $0.26/share (YE 04)
Average shares outstanding 30.877M (YE 05) compared to 27.553M (YE
04)
Total assets $106.998M (YE 05) compared to $72.093M (YE 04)
PRIVATE PLACEMENTS: $5.3M in an offering of 265K units at $20/unit (11/94)
Raised $12.4M in private placement (11/96)
Raised $15.7M in private placement of 3.7M shares of common stock at
$4.25/share (2003)
Copyright ©2006 AHC Media ® 224
6/06